ロード中...
BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion
Prostate cancer (PCa) that becomes resistant to hormone castration and next-generation androgen receptor (AR)-targeted therapies, called castration-resistant prostate cancer (CRPC), poses a significant clinical challenge. A better understanding of PCa progression and key molecular mechanisms could b...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122392/ https://ncbi.nlm.nih.gov/pubmed/27223260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9513 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|